GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acro Biomedical Co Ltd (ROCO:6748) » Definitions » Selling and Marketing Expense

Acro Biomedical Co (ROCO:6748) Selling and Marketing Expense : NT$20.32 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acro Biomedical Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Acro Biomedical Co's Selling and Marketing Expense for the six months ended in Dec. 2024 was NT$12.69 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$20.32 Mil.

Acro Biomedical Co Selling and Marketing Expense Historical Data

The historical data trend for Acro Biomedical Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Selling and Marketing Expense Chart

Acro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial 10.20 12.46 17.88 18.02 20.32

Acro Biomedical Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.61 10.03 7.99 7.63 12.69

Acro Biomedical Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$20.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acro Biomedical Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acro Biomedical Co Ltd (ROCO:6748) » Definitions » Selling and Marketing Expense
Comparable Companies
ROCO:6676 ROCO:6461 ROCO:4130 TPE:1762 ROCO:1295 ROCO:6704 ROCO:6892 ROCO:7754 ROCO:6580 ROCO:6846 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
3rd Floor, No. 57, Luke 2nd Road, Luzhu District, Kaohsiung, TWN
Website
https://www.acrobiomedical.com
Acro Biomedical Co Ltd is a company whose technical team integrates the Research and development capabilities of Taiwan's major scientific research units and medical centers to jointly develop equipment for repairing organs and tissues in various parts of the human body. It mainly focuses on orthopedics, dentistry, cardiovascular specialists, ophthalmology, surgery, wound care, Medical equipment used in sports injuries and other specialties.

Acro Biomedical Co Headlines

No Headlines